Shifting unoccupied spectral space in mass spectrum of peptide fragment ions.
Ions near the high-end border of a mass defect distribution plot for native peptide fragment ions have potential as signature markers that are based on mass-to-charge ratio determination. The specificity of these marker ions, including phosphoryl ions, can be improved by removing interfering isobaric ions from the border region on the distribution plot. These interfering ions are rich in Asp and Glu content. The masses of amino acid residues and peptides are rescaled from the IUPAC scale (12C = 12 u as the mass reference) to the averagine scale (averagine mass = 111 u* as the mass reference with zero mass defect; u*: the mass unit on the averagine scale), using a scaling factor of 0.999493894. It is theoretically predicted that esterification of Asp and Glu side-chain carboxylates with n-butanol can achieve a sufficient retreat of the high-end border on a mass defect distribution plot based on the use of mass spectrometers with better-than-medium resolution. Theoretical calculations and laboratory experiments are performed to examine effects of various esterifications on the averagine-scale mass defect distribution of peptide fragment ions and on the specificity of two positive phosphoryl ions: the phosphotyrosine immonium ion and a cyclophosphoramidate ion.
Bajrami
Bekim
B
Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269-3060, USA.
Shi
Yu
Y
Lapierre
Pascal
P
Yao
Xudong
X
D020001:1-Butanol / Q000737:chemistry; D000595:Amino Acid Sequence; D000818:Animals; D001216:Asparagine / Q000737:chemistry; D002417:Cattle; D002645:Chickens; D002853:Chromatography, Liquid; D004951:Esterification; D018698:Glutamic Acid / Q000737:chemistry; D007477:Ions / Q000737:chemistry*; D013058:Mass Spectrometry / Q000379:methods*; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry*; D017433:Protein Structure, Secondary; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry
D007477:Ions; D010446:Peptide Fragments; D018698:Glutamic Acid; D001216:Asparagine; D020001:1-Butanol
J Mass Spectrom. 2003 Aug;38(8):809-16
12938101
J Mass Spectrom. 2000 Nov;35(11):1335-41
11114093
Anal Chem. 2006 Jul 1;78(13):4374-82
16808444
Anal Biochem. 2008 Jan 15;372(2):156-66
17980142
Proteomics. 2003 Jun;3(6):847-50
12833507
J Mass Spectrom. 2000 Aug;35(8):939-52
10972994
J Proteome Res. 2006 May;5(5):1195-203
16674109
Anal Chem. 2001 Oct 1;73(19):4676-81
11605846
J Mass Spectrom. 2001 Jul;36(7):782-90
11473401
Anal Chem. 2008 Oct 1;80(19):7383-91
18778085
Anal Chem. 2007 Nov 15;79(22):8454-62
17949060
Anal Chem. 2001 Apr 1;73(7):1440-8
11321292
Anal Chem. 2003 Jun 1;75(11):2724-9
12948142
Annu Rev Pharmacol Toxicol. 2009;49:199-221
18834307
Anal Chem. 2006 May 15;78(10):3417-23
16689545
Anal Chem. 2008 Oct 1;80(19):7614-23
18781815
Rapid Commun Mass Spectrom. 2002;16(18):1714-22
12207358
Methods Enzymol. 2005;405:82-115
16413312
J Am Soc Mass Spectrom. 2003 Sep;14(9):943-56
12954163
J Am Soc Mass Spectrom. 1995 Apr;6(4):229-33
24214167
Electrophoresis. 1999 Dec;20(18):3527-34
10612279
J Mass Spectrom. 2008 Aug;43(8):1081-8
18320553
Anal Chem. 2007 Jun 1;79(11):3989-95
17477508
J Mass Spectrom. 2006 Mar;41(3):281-8
16538648
Anal Chem. 2009 Aug 1;81(15):6438-48
19572545
Expert Rev Proteomics. 2004 Dec;1(4):421-31
15966839
Anal Chem. 2006 Jun 15;78(12):4175-83
16771548
Rapid Commun Mass Spectrom. 2001;15(14):1214-21
11445905
Anal Chem. 2006 Sep 15;78(18):6391-7
16970313
Eur J Mass Spectrom (Chichester). 2008;14(5):311-7
19023148
Mol Cell Proteomics. 2007 Mar;6(3):377-81
17164402
Anal Chem. 2004 Dec 1;76(23):6848-52
15571332
Mol Cell Proteomics. 2006 Jan;5(1):144-56
16219938
J Am Chem Soc. 2008 Feb 20;130(7):2122-3
18220392